NIM
ABBV icon

Northeast Investment Management’s AbbVie ABBV Stock Holding History

Northeast Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.03M Buy
12,037
+17
+0.1% +$3.66K 0.11% 78
2026
Q1 		$2.61M Sell
12,020
-191
-2% -$42.4K 0.11% 77
2025
Q4 		$2.79M Buy
12,211
+685
+6% +$156K 0.11% 74
2025
Q3 		$2.67M Sell
11,526
-341
-3% -$69.4K 0.11% 76
2025
Q2 		$2.2M Sell
11,867
-171
-1% -$31.8K 0.09% 81
2025
Q1 		$2.52M Sell
12,038
-73
-0.6% -$14.2K 0.12% 76
2024
Q4 		$2.15M Buy
12,111
+147
+1% +$27K 0.1% 79
2024
Q3 		$2.36M Sell
11,964
-102
-0.8% -$19K 0.11% 81
2024
Q2 		$2.07M Buy
12,066
+369
+3% +$61.1K 0.1% 83
2024
Q1 		$2.13M Hold
11,697
– – 0.1% 81
2023
Q4 		$1.81M Sell
11,697
-1,156
-9% -$169K 0.1% 83
2023
Q3 		$1.92M Sell
12,853
-1,233
-9% -$181K 0.11% 84
2023
Q2 		$1.9M Sell
14,086
-47
-0.3% -$6.89K 0.11% 80
2023
Q1 		$2.25M Sell
14,133
-476
-3% -$72.8K 0.14% 79
2022
Q4 		$2.36M Sell
14,609
-1,978
-12% -$303K 0.15% 81
2022
Q3 		$2.23M Sell
16,587
-108
-0.6% -$15.5K 0.15% 78
2022
Q2 		$2.56M Buy
16,695
+332
+2% +$50.7K 0.16% 76
2022
Q1 		$2.65M Buy
16,363
+260
+2% +$37.8K 0.14% 78
2021
Q4 		$2.18M Buy
16,103
+1,410
+10% +$167K 0.11% 87
2021
Q3 		$1.58M Buy
14,693
+839
+6% +$95.9K 0.08% 96
2021
Q2 		$1.56M Buy
13,854
+74
+0.5% +$8.33K 0.08% 101
2021
Q1 		$1.49M Buy
13,780
+866
+7% +$92.6K 0.09% 96
2020
Q4 		$1.38M Hold
12,914
– – 0.08% 98
2020
Q3 		$1.13M Hold
12,914
– – 0.08% 96
2020
Q2 		$1.27M Hold
12,914
– – 0.09% 90
2020
Q1 		$984K Sell
12,914
-592
-4% -$50.4K 0.09% 89
2019
Q4 		$1.2M Buy
13,506
+34
+0.3% +$2.82K 0.09% 97
2019
Q3 		$1.02M Sell
13,472
-811
-6% -$55.6K 0.08% 99
2019
Q2 		$1.04M Buy
14,283
+4,896
+52% +$385K 0.08% 99
2019
Q1 		$756K Sell
9,387
-564
-6% -$46.1K 0.06% 102
2018
Q4 		$917K Buy
9,951
+179
+2% +$15.7K 0.09% 96
2018
Q3 		$924K Sell
9,772
-279
-3% -$26.5K 0.07% 103
2018
Q2 		$931K Buy
10,051
+38
+0.4% +$3.71K 0.08% 102
2018
Q1 		$948K Sell
10,013
-20
-0.2% -$2.2K 0.08% 98
2017
Q4 		$970K Sell
10,033
-21
-0.2% -$1.98K 0.08% 99
2017
Q3 		$893K Buy
10,054
+1,642
+20% +$125K 0.08% 98
2017
Q2 		$610K Sell
8,412
-210
-2% -$14.1K 0.06% 109
2017
Q1 		$562K Sell
8,622
-1,385
-14% -$87.1K 0.05% 111
2016
Q4 		$627K Buy
10,007
+384
+4% +$23.4K 0.06% 105
2016
Q3 		$607K Sell
9,623
-249
-3% -$16.1K 0.06% 106
2016
Q2 		$611K Sell
9,872
-32
-0.3% -$1.95K 0.06% 109
2016
Q1 		$566K Sell
9,904
-275
-3% -$15.3K 0.06% 111
2015
Q4 		$603K Sell
10,179
-131
-1% -$7.54K 0.06% 112
2015
Q3 		$561K Sell
10,310
-1,586
-13% -$103K 0.06% 111
2015
Q2 		$799K Sell
11,896
-60
-0.5% -$3.92K 0.08% 107
2015
Q1 		$700K Sell
11,956
-658
-5% -$39.8K 0.07% 109
2014
Q4 		$825K Buy
12,614
+549
+5% +$34.6K 0.08% 109
2014
Q3 		$697K Buy
12,065
+685
+6% +$38K 0.07% 117
2014
Q2 		$642K Sell
11,380
-6
-0.1% -$315 0.06% 119
2014
Q1 		$585K Sell
11,386
-578
-5% -$29.2K 0.06% 116
2013
Q4 		$632K Buy
11,964
+445
+4% +$21.9K 0.07% 113
2013
Q3 		$515K Sell
11,519
-185
-2% -$8.2K 0.06% 115
2013
Q2 		$484K Buy
+11,704
New +$512K 0.06% 114

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Northeast Investment Management's ABBV Position: Q2 2026 in Review

Northeast Investment Management increased its AbbVie (ABBV) stake by 0.14% in Q2 2026, buying an estimated $3.66K and bringing the position to 12,037 shares worth $3.03M. The position accounts for 0.11% of the portfolio, ranked #78.

Northeast Investment Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Northeast Investment Management held 12,037 shares of AbbVie worth $3.03M as of Q2 2026.
  • Northeast Investment Management bought 17 AbbVie shares in Q2 2026, an estimated $3.66K.
  • AbbVie made up 0.11% of Northeast Investment Management's portfolio in Q2 2026, its #78 holding.
  • Northeast Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Northeast Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.